Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.8 CHF | +1.15% | +4.35% | -26.26% |
Mar. 08 | Switzerland's Coltene Appoints Successor to Outgoing Chair | MT |
Mar. 08 | Switzerland's Coltene Logs Lower FY23 Net Profit, Sales | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- This company will be of major interest to investors in search of a high dividend stock.
- Sales forecast by analysts have been recently revised upwards.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-26.26% | 349M | B- | ||
-3.79% | 184B | C+ | ||
-0.84% | 108B | C | ||
-3.75% | 67.8B | A | ||
+3.45% | 51.05B | B- | ||
+9.04% | 44.67B | B- | ||
+3.40% | 41.78B | B+ | ||
+3.21% | 26.78B | B | ||
+3.66% | 26.59B | A- | ||
+15.23% | 25.86B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CLTN Stock
- Ratings COLTENE Holding AG